A Study to Test the Effects of Nezavist at Different Doses in Healthy Adults
type: MedicalStudy
description: A Phase 1a Randomized, Double-blind, Placebo-controlled, Single Site, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Nezavist in Healthy Adults
status: ACTIVE_NOT_RECRUITING
study design: INTERVENTIONAL
phase: PHASE1
start date: 2025-02-28
end date: 2027-05-01
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT06633562
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Lohocla Research Corporation
study subject: Healthy
study subject: Safety Evaluation of Escalating Doses
study subject: Tolerability
keywords: PHASE1
keywords: INTERVENTIONAL
keywords: ACTIVE_NOT_RECRUITING
keywords: Healthy
keywords: Safety Evaluation of Escalating Doses
keywords: Tolerability

AI Analytics
type: Organization